Zoll Medical said today that it acquired healthcare software solution developer Payor Logic for an undisclosed amount. Centerville, Ohio-based Payor Logic develops and supports accounts receivable software solutions specifically for the healthcare industry. The solutions are intended for use by emergency medical services, emergency physicians, DME providers, hospitals and labs, Zoll said. “In today’s environment, […]
Zoll Medical
Study: Wearable defibrillators don’t work unless you wear them
An electric-shock vest that can detect arrhythmias in heart attack patients reduced deaths among those who wore it as prescribed, according to a study published today in the New England Journal of Medicine. The highly sensitive wearable cardiac defibrillator (WCD) known as the Zoll LifeVest can deliver an electric shock when the heart beats out […]
Zoll claims $5m win in AutoMedx dispute
Zoll Medical said today that it won more than $5 million with an arbitrator’s decision in its spat with former partner AutoMedx. Coppell, Texas-based AutoMedx sued the Asahi Kasei (TYO:3407) subsidiary in 2015, alleging breach of contract after Zoll’s Advanced Circulatory Control Systems business spiked a product development deal “due to AutoMedx’s failure to perform,” Zoll […]
FDA updates on Zoll Medical LifeVest 4000 error 102 issues
The FDA today updated on a previous voluntary recall of Asahi Kasei (TYO:3407) subsidiary Zoll Medical‘s LifeVest wearable automatic external defibrillators over errors that can cause the device to stop functioning, saying the company has initiated new customer training on the device and is working on a software fix. In January, the FDA released a warning and […]
Zoll Medical leads debt round for TherOx
TherOx said today it completed a new round of debt financing led by Asahi Kasei (TYO:3407) subsidiary Zoll Medical for an undisclosed amount. Funds from the deal will be used to support the US market introduction and commercialization of the Irvine, Calif.-based company’s SuperSaturated Oxygen Therapy system designed to treat patients with acute myocardial infarction once the system […]
ACC ’18 Roundup: Abbott releases long-term HeartMate 3 data
Abbott (NYSE:ABT) touted two-year data yesterday from its trial designed to compare the company’s HeartMate 3 left ventricular assist device to its HeartMate 2 device in patients with advanced heart failure. Data from the study were published in The New England Journal of Medicine and presented at the American College of Cardiology’s 67th Annual Scientific Session. More […]
Appeals court revives lawsuit over death allegedly linked to Zoll’s LifeVest
Asahi Kasei (TYO:3407) subsidiary Zoll Medical is facing a revived suit alleging that the company’s LifeVest failed to appropriately shock a patient’s heart, resulting in her death. The case was filed by Dennis Godelia, remaining son of deceased Debra Godelia, who died in 2013 after the LifeVest allegedly did not function correctly during a “defibrillation event,” court documents […]
7 medtech stories we missed this week: Jan. 19, 2018
From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news […]
Death prompts warning for Zoll’s LifeVest wearable AED
Asahi Kasei (TYO:3407) subsidiary Zoll Medical and the FDA are warning about an error code displayed by a model of its LifeVest wearable automatic external defibrillator that was involved in a patient’s death. Patients using LifeVest 4000 models who don’t contact the company after the device displays “Call for service: Device has a problem that may […]
Zoll Medical wins US Army contract for Propaq M vital signs monitors
Zoll Medical said this week it won a sole-source contract from the US Defense Logistics Agency to supply Propaq M deployable vital signs monitors to the US Air Force and US Army. The Chelmsford, Mass.-based company’s Propaq M is an advanced vital signs transport monitor designed for military operations. The system can be equipped with an […]
Zoll leads $59m Respicardia funding round
Respicardia said today it closed a $58.5 million financing round led by Zoll Medical to support commercialization efforts related to its Remede transvenous implantable neurostimulation system designed to treat patients with central sleep apnea. The Remedē system consists of a surgically placed battery pack and thin wires inserted into the blood vessels in the chest near the […]